Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
A retrospective, passive surveillance study describing resistance prevalence and trends across 29 years without a comparator group, control arm, or intervention—descriptive epidemiology that raises questions about resistance emergence rather than testing a hypothesis or guiding treatment.
A large retrospective genomic surveillance study describing resistance prevalence and trends across 7,691 isolates, but without clinical outcomes, intervention comparisons, or mechanistic validation to support practice-changing or strong evidence.
A large cross-sectional surveillance study in asymptomatic carriers with genomic characterization, but descriptive in design with no comparator group, control arm, or hypothesis test; provides epidemiological baseline data rather than evaluating an intervention or clinical outcome.